These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26049343)

  • 41. [Oral antidiabetic agents--2. Individualized stepwise therapy].
    Bachmann W
    MMW Fortschr Med; 2000 Mar; 142(10):36-8. PubMed ID: 10748602
    [No Abstract]   [Full Text] [Related]  

  • 42. EVALUATION OF TOTAL DAILY DOSE AND GLYCEMIC CONTROL FOR PATIENTS TAKING U-500 REGULAR INSULIN ADMITTED TO THE HOSPITAL.
    Paulus AO; Colburn JA; True MW; Beckman DJ; Davis RP; Wardian JL; Graybill SD; Folaron I; Lewi JE
    Endocr Pract; 2016 Oct; 22(10):1187-1191. PubMed ID: 27359287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
    Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An evaluation of the protective role of Ficus racemosa Linn. in streptozotocin-induced diabetic neuropathy with neurodegeneration.
    Solanki ND; Bhavsar SK
    Indian J Pharmacol; 2015; 47(6):610-5. PubMed ID: 26729951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement in Neuropathy Outcomes With Normalizing HbA
    Ishibashi F; Taniguchi M; Kosaka A; Uetake H; Tavakoli M
    Diabetes Care; 2019 Jan; 42(1):110-118. PubMed ID: 30455338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 47. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):14-6. PubMed ID: 19938773
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modifiable vascular risk factors are associated with diabetic neuropathy in type 1 diabetes.
    Blomeier H; Jameson JL
    Postgrad Med; 2005 Apr; 117(4):7. PubMed ID: 15842127
    [No Abstract]   [Full Text] [Related]  

  • 50. Outcomes of diabetes patients attending a hospital diabetes clinic.
    Siu SC; Lo SK; Wong KW
    Diabetes Res Clin Pract; 2004 Apr; 64(1):73-4. PubMed ID: 15036830
    [No Abstract]   [Full Text] [Related]  

  • 51. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery.
    Hikata T; Iwanami A; Hosogane N; Watanabe K; Ishii K; Nakamura M; Toyama Y; Matsumoto M; Kamata M
    J Orthop Sci; 2014 Mar; 19(2):223-228. PubMed ID: 24368606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The International Diabetes Federation’s 2013 World Diabetes Congress, Melbourne, Australia.
    J Diabetes; 2014 May; 6(3):197-201. PubMed ID: 24418324
    [No Abstract]   [Full Text] [Related]  

  • 54. Influencing factors of glycaemic control in patients attending different types of urban health care settings in Malaysia.
    Ahmad B; Khalid BA; Zaini A; Hussain NA; Quek KF
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e12-4. PubMed ID: 21397969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2005 Jul; 28(7):1834-5. PubMed ID: 15983352
    [No Abstract]   [Full Text] [Related]  

  • 56. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A
    MMW Fortschr Med; 2015 Apr; 157(7):65-8. PubMed ID: 26012462
    [No Abstract]   [Full Text] [Related]  

  • 57. Physical activity, glycemic control, and diabetic peripheral neuropathy: a national sample.
    Loprinzi PD; Hager KK; Ramulu PY
    J Diabetes Complications; 2014; 28(1):17-21. PubMed ID: 24090951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. As U-500 Insulin Safety Concerns Mount, It's Time to Rethink Safe Use of Strengths Above U-100.
    Shastay A
    Home Healthc Now; 2015 Oct; 33(9):501-2. PubMed ID: 26418111
    [No Abstract]   [Full Text] [Related]  

  • 59. [Are peroral antidiabetic agents neurotoxic?].
    Kalita Z
    Cas Lek Cesk; 1990 Dec; 129(51):1601-4. PubMed ID: 2076524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
    Fordan S; Raskin P
    Vasc Health Risk Manag; 2009; 5(1):225-31. PubMed ID: 19436644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.